Hematology Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Myeloproliferative neoplasms"

Mutations in the ALK gene were identified in the tumors of two leukemia patients, and laboratory studies indicated that leukemias harboring these mutations may respond to ALK inhibitors such as Crizot ...

There are considerable advances in the understanding of the Philadelphia-chromosome (Ph)-negative myeloproliferative neoplasms ( MPN ) in the past 10 years including unraveling the mutation topography ...